Ind-Swift Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve the Unaudited Financial ....
INDSWFTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ind-Swift Laboratories has informed the stock exchanges that its Board of Directors will meet on Friday, November 14, 2025, to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended September 30, 2025. The notice is filed under Regulation 29 of SEBI LODR. The company also references a prior communication (dated September 27, 2025) regarding the closure of the trading window for insiders. No financial figures or specific agenda items beyond the quarterly results are disclosed.
This is a routine regulatory filing ahead of Q2/H1 FY26 results — no new information for shareholders yet. Investors should watch for the actual results announcement on or after November 14, 2025 for any updates on revenue, profitability, and outlook.